IPSEY Company Profile and Key Details

Q: Who are the executives of IPSEY?

Mr. Regis MulotExecutive Vice President & Chief HR OfficerMr. Stephan GagneHead of New Tokyo OfficeDr. Yan Moore M.D.Chief Medical OfficerMs. Dominique BeryHead of Nordics & BalticsMs. Gwenan WhiteExecutive Vice President of Communications & Public AffairsDr. Alexander McEwanVice-Pres & Head of RadiopharmaceuticalsMr. David LoewMD, Chief Executive Officer & DirectorMr. Francois GarnierExecutive Vice President of Legal Affairs, Gen. Counsel & Chief Bus. Ethics OfficerDr. Aidan Murphy Ph.D.Executive Vice President of Technical OperationsMr. Aymeric Le ChatelierExecutive Vice President & Group Chief Financial OfficerMr. Craig MarksVice-Pres of Investor Relations

OTC : IPSEY

Ipsen SA

$48.86

Open: 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Ipsen S.A. (IPSEY) stock remained unchanged at $48.86 a share on OTC. The stock opened at $50.88, fluctuating between $48.86 to $50.88 during the session.

Stock Snapshot

48.86

Prev. Close

64.61B

Market Cap

48.86

Day Low

31.32

P/E Ratio

1.56

EPS (TTM)

7.99

Cash Flow per Share

50.88

Open

1.32B

Number of Shares

50.88

Day High

9.24%

Free Float in %

46.29

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 08, 2026	48.86	48.86	48.86	48.86	10.87K
May 07, 2026	50.88	50.88	50.88	50.88	2
May 06, 2026	50.70	50.70	50.70	50.70	163
May 05, 2026	49.71	51.10	49.71	50.60	1.92K
Apr 30, 2026	49.09	49.09	49.09	49.09	2.42K
Apr 29, 2026	49.80	49.80	49.80	49.80	129
Apr 28, 2026	47.95	47.95	47.95	47.95	454
Apr 27, 2026	47.95	47.95	47.95	47.95	271
Apr 23, 2026	48.01	48.01	48.01	48.01	205
Apr 17, 2026	48.55	48.55	48.55	48.55	155
Apr 14, 2026	49.15	49.15	49.15	49.15	107
Apr 08, 2026	48.54	48.88	48.54	48.88	464
Apr 07, 2026	48.54	48.54	48.54	48.54	474
Apr 02, 2026	48.54	48.54	48.54	48.54	1.28K
Apr 01, 2026	48.00	48.21	48.00	48.21	441
Mar 31, 2026	45.76	46.30	45.76	46.30	449
Mar 30, 2026	44.01	44.01	44.01	44.01	245
Mar 25, 2026	42.73	42.73	42.73	42.73	16
Mar 23, 2026	43.23	43.23	43.09	43.09	8.43K
Mar 18, 2026	44.63	44.63	44.63	44.63	697

Contact Details

Boulogne-Billancourt, 92100

France

https://www.ipsen.com 331 583 35000

About Company

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. The company also offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. In addition, it provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Protect, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Further, the company offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Braintree Laboratories; Ethypharm; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.

Stock Peers

MKGAF

-6.5-3.38%

MERCK Kommanditgesellschaft auf Aktien$186.00 HKMPY

-0.87-1.69%

Hikma Pharmaceuticals PLC$50.66 SGIOF

Shionogi & Co., Ltd.$43.89 ESALF

Eisai Co., Ltd.$43.00 MKKGY

-0.85-2.24%

MERCK Kommanditgesellschaft auf Aktien$37.11 TKPHF

Takeda Pharmaceutical Company Limited$26.83 TEVJF

5.26+43.91%

Teva Pharmaceutical Industries Limited$17.24 APNHY

Aspen Pharmacare Holdings Limited$12.52 TAIPY

Taisho Pharmaceutical Holdings Co., Ltd.$12.00 GTBIF

-0.38-3.20%

Green Thumb Industries Inc.$11.49

Company Overview

The stock is currently within 5% of its 52-week high $28.46 and $51.10. With a market capitalization of about $64.61 billion, Ipsen S.A. is classified as a large-cap and shows lower-than-market volatility (beta ~0.33). Key stats such as the average daily volume over the past year has been around 830.00 shares, volume is running light vs its 52-week average. Headquartered in Boulogne-Billancourt, None, Ipsen S.A. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO David Loew, the company employs approximately 5,358 people and listed since August 03, 2012. Ipsen S.A.

Technical Performance

Average 10-day trading volume of 3.24 thousand shares is significantly above the 3-month average of 1.69 thousand, indicating heightened recent market interest.

Valuation Metrics

Ipsen S.A. trades at a P/E ratio of 32.08, slightly below the S&P 500 average, with a price-to-sales ratio of 15.11 and a price-to-book ratio of 3.28 trading at moderately above to book value. The P/FCF stands at 53.94, also above market averages.

Dividend & Fair Value

Ipsen S.A. last paid a dividend of 0.4 per share, this equals a trailing yield of roughly inf%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $62.72. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Ipsen S.A. earnings surprise history is a mixed track record. The quarter that ended February 12, 2026, missed forecasts by 9.15%. The prior quarter beat by -27.61%. Over the last six quarters, Apple has recorded several small beats. These include -5.63% in April 24, 2024.

Financial & Profitability Overview

Over the trailing twelve months, Ipsen SA generated $3.13B in revenue, or $37.51 per share. Gross margin was 75.10%, operating margin 20.75%, and net profit margin 20.60%. Returns are healthy, with ROA at 10.19% and ROE at 16.85%.
On valuation metrics, Ipsen SA trades at a P/E of 32.08, P/S of 15.11 and P/B of 3.28. The current ratio is 1.96 and quick ratio is 1.78. Operationally, the company’s inventory turnover is 3.43 and cash conversion cycle is -158.05 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.24, supported by a cash flow-to-debt ratio of 1.11.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Ipsen SA posted revenue of $3.13B, down slightly from $3.16B in the prior quarter. Gross profit was $2.35B (margin 75.10%). Operating income was $648.90M (margin 20.7%). Net income was$644.40M (EPS $7.79).
The company ended the quarter with $528.40M in cash and short-term investments, a total debt of $462.90M, and net debt of - $65.50M. Total assets were $6.32B, with equity of $3.82B. Financials further reflected stability, with operating cash flow of $843.30M, free cash flow of $660.40M, and capital expenditures of - $182.90M.

Price Forecast & Outlook

Our AI price prediction model suggests that Ipsen S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Ipsen S.A. trading at a premium to the broader market with a P/E of 32.08.

Frequently Asked Questions

What is the current Ipsen S.A. (IPSEY) stock price?

Ipsen S.A. (OTC: IPSEY) stock price is $48.86 in the last trading session. During the trading session, IPSEY stock reached the peak price of $50.88 while $48.86 was the lowest point it dropped to. The percentage change in IPSEY stock occurred in the recent session was 0% while the dollar amount for the price change in IPSEY stock was $0.00.

IPSEY's industry and sector of operation?

The OTC listed IPSEY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Ipsen S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IPSEY?

Mr. Regis Mulot
Executive Vice President & Chief HR Officer
Mr. Stephan Gagne
Head of New Tokyo Office
Dr. Yan Moore M.D.
Chief Medical Officer
Ms. Dominique Bery
Head of Nordics & Baltics
Ms. Gwenan White
Executive Vice President of Communications & Public Affairs
Dr. Alexander McEwan
Vice-Pres & Head of Radiopharmaceuticals
Mr. David Loew
MD, Chief Executive Officer & Director
Mr. Francois Garnier
Executive Vice President of Legal Affairs, Gen. Counsel & Chief Bus. Ethics Officer
Dr. Aidan Murphy Ph.D.
Executive Vice President of Technical Operations
Mr. Aymeric Le Chatelier
Executive Vice President & Group Chief Financial Officer
Mr. Craig Marks
Vice-Pres of Investor Relations

How IPSEY did perform over past 52-week?

IPSEY's closing price is 22.36% higher than its 52-week low of $28.46 where as its distance from 52-week high of $51.10 is -3.9%.

How many employees does IPSEY have?

Number of IPSEY employees currently stands at 5,358.

Link for IPSEY official website?

Official Website of IPSEY is: https://www.ipsen.com

How do I contact IPSEY?

IPSEY could be contacted at phone 331 583 35000 and can also be accessed through its website. IPSEY operates from 65 Quai Georges Gorse, Boulogne-Billancourt, 92100, France.

How many shares of IPSEY are traded daily?

IPSEY stock volume for the day was 2 shares. The average number of IPSEY shares traded daily for last 3 months was 830.

What is the market cap of IPSEY currently?

The market value of IPSEY currently stands at $64.61B with its latest stock price at $48.86 and 1.32B of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5358
Beta	0.34
Sales or Revenue	$3.13B
5Y Sales Change%	0.418%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

IPSEY Company Profile and Key Details

Ipsen SA

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways